Antisense compounds, compositions and methods are provided for modulating
the expression of fibroblast growth factor receptor 2. The compositions comprise
antisense compounds, particularly antisense oligonucleotides, targeted to nucleic
acids encoding fibroblast growth factor receptor 2. Methods of using these compounds
for modulation of fibroblast growth factor receptor 2 expression and for treatment
of diseases associated with expression of fibroblast growth factor receptor 2 are provided.
